Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Isonicotinic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111138354A reveals a novel isoniazid preparation method achieving 99.99% purity. Discover cost-effective scale-up strategies for this critical API intermediate.
Novel green synthesis patent CN109851551A offers high purity intermediates. Reduces heavy metal waste and improves supply chain reliability for global buyers.
Patent CN107354477A reveals green electrochemical synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Curtius rearrangement method for 4-amino-2,6-dichloropyridine. High purity, avoids explosive azides. Ideal for API manufacturing.
Patent CN101863830A reveals a high-yield synthesis of 2-amino-5-bromoisonicotinic acid (>60%), offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel cobalt-catalyzed CO2 carboxylation patent offers cost-effective route for high-purity isonicotinic acid intermediates, enhancing supply chain reliability for global pharma manufacturing.
Patent CN117430549A details a green copper-catalyzed method for isonicotinic acid using CO2. Offers mild conditions and supply chain advantages for pharma intermediates.